Skip to main content
. Author manuscript; available in PMC: 2014 Aug 15.
Published in final edited form as: Cancer Res. 2013 Aug 15;73(16):5163–5168. doi: 10.1158/0008-5472.CAN-13-0427

Table 1.

Clinical characteristics of PHS and HPFS prostate cancer cases with re-reviewed Gleason score and clinical stage

PHS (N=420) HPFS (N=787)
Years of diagnosis, range 1982–2004 1986–2004
Age at diagnosis, mean (s.d.) 66.1 (6.2) 65.6 (6.2)
Re-reviewed Gleason score (%)
    2–6 125 (29.8) 142 (18.0)
    7 (3+4) 151 (36.0) 295 (37.5)
    7 (4+3) 77 (18.3) 189 (24.0)
    8–10 67 (16.0) 161 (20.4)
Clinical stage (%)
    T1/T2 392 (93.3) 713 (90.6)
    T3 25 (6.0) 48 (6.1)
    T4/N1/M1 3 (0.1) 26 (3.3)